Related references
Note: Only part of the references are listed.An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
Juan P. Arab et al.
HEPATOLOGY (2020)
IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver Failure
Katharina Schwarzkopf et al.
HEPATOLOGY COMMUNICATIONS (2019)
Role of Interleukin-22 in chronic liver injury
Rodrigo F. Carmo et al.
CYTOKINE (2017)
IL-22 and IL-22 Binding Protein (IL-22BP) Regulate Fibrosis and Cirrhosis in Hepatitis C Virus and Schistosome Infections
Mathieu Sertorio et al.
HEPATOLOGY (2015)
Viral and host immune regulatory mechanisms in hepatitis C virus infection
Mario U. Mondelli et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity
SV Kotenko et al.
JOURNAL OF IMMUNOLOGY (2001)